The electrophoretic mobility of BP8 ascites tumour cells and allergized lymph-node cells after treatment with inflammatory mediators, ptomaines, polyamines, antisera and neuraminidase or heparin.
D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002284:Carcinoma, Brown-Pearce; D002448:Cell Adhesion / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects*; D004586:Electrophoresis; D006493:Heparin / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006967:Hypersensitivity; D007106:Immune Sera / Q000494:pharmacology; D066298:In Vitro Techniques; D037102:Lectins / Q000494:pharmacology; D008198:Lymph Nodes / Q000166:cytology* / Q000276:immunology; D008239:Lysine / Q000494:pharmacology; D051379:Mice; D009439:Neuraminidase / Q000494:pharmacology; D011073:Polyamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011479:Protamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013096:Spermine / Q000494:pharmacology
D007106:Immune Sera; D037102:Lectins; D011073:Polyamines; D011479:Protamines; D013096:Spermine; D006632:Histamine; D006493:Heparin; D009439:Neuraminidase; D008239:Lysine; D001920:Bradykinin